This paper considers the prerequisites for gene therapy. This new fiel
d of therapeutics has not yet proved its efficacity nor its safety. Us
e, as a drug of DNA molecules which can modify host genome and environ
ment as well requires specific prerequisites; among them, animal exper
imental models are essential despite their limitations. The different
preclinical and clinical steps in the design of gene therapy studies a
re also discussed.